Search

Chau D. Le

Examiner (ID: 7847, Phone: (571)270-7217 , Office: P/2493 )

Most Active Art Unit
2493
Art Unit(s)
2447, 2493, 2408
Total Applications
807
Issued Applications
659
Pending Applications
54
Abandoned Applications
115

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 18628343 [patent_doc_number] => 20230287205 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-09-14 [patent_title] => DISSOLVABLE SOLID STRUCTURE HAVING FIRST AND SECOND LAYERS [patent_app_type] => utility [patent_app_number] => 18/181675 [patent_app_country] => US [patent_app_date] => 2023-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11565 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18181675 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/181675
Dissolvable solid structure having first and second layers Mar 9, 2023 Issued
Array ( [id] => 19417220 [patent_doc_number] => 20240293343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-09-05 [patent_title] => Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications [patent_app_type] => utility [patent_app_number] => 18/109031 [patent_app_country] => US [patent_app_date] => 2023-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17014 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18109031 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/109031
Benzylideneaminoguanidine derivatives as NR2B-selective NMDA receptor antagonists and their therapeutic applications Feb 12, 2023 Pending
Array ( [id] => 18389961 [patent_doc_number] => 20230158179 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-05-25 [patent_title] => RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/989479 [patent_app_country] => US [patent_app_date] => 2022-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41684 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17989479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/989479
RADIOPHARMACEUTICAL CONJUGATE COMPOSITIONS AND USES THEREOF Nov 16, 2022 Abandoned
Array ( [id] => 17836269 [patent_doc_number] => 20220273574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-09-01 [patent_title] => ORGANIC COMPOUNDS [patent_app_type] => utility [patent_app_number] => 17/748432 [patent_app_country] => US [patent_app_date] => 2022-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4195 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17748432 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/748432
ORGANIC COMPOUNDS May 18, 2022 Abandoned
Array ( [id] => 17760016 [patent_doc_number] => 20220233628 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-28 [patent_title] => PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 17/712479 [patent_app_country] => US [patent_app_date] => 2022-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20036 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17712479 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/712479
PLASMONICS-ACTIVE METAL NANOSTAR COMPOSITIONS AND METHODS OF USE Apr 3, 2022 Pending
Array ( [id] => 17827930 [patent_doc_number] => 20220265234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-25 [patent_title] => Radiographic Contrast Agents For Temporal Subtraction And Dual-Energy X-Ray Imaging [patent_app_type] => utility [patent_app_number] => 17/711156 [patent_app_country] => US [patent_app_date] => 2022-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10294 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17711156 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/711156
Radiographic Contrast Agents For Temporal Subtraction And Dual-Energy X-Ray Imaging Mar 31, 2022 Pending
Array ( [id] => 17702959 [patent_doc_number] => 20220202965 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-30 [patent_title] => RADIOTRACER COMPOSITIONS AND METHODS [patent_app_type] => utility [patent_app_number] => 17/695810 [patent_app_country] => US [patent_app_date] => 2022-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17695810 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/695810
RADIOTRACER COMPOSITIONS AND METHODS Mar 14, 2022 Abandoned
Array ( [id] => 17593656 [patent_doc_number] => 20220143229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-05-12 [patent_title] => RADIO-PHARMACEUTICAL COMPLEXES [patent_app_type] => utility [patent_app_number] => 17/581808 [patent_app_country] => US [patent_app_date] => 2022-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13026 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17581808 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/581808
RADIO-PHARMACEUTICAL COMPLEXES Jan 20, 2022 Abandoned
Array ( [id] => 18253444 [patent_doc_number] => 20230080483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2023-03-16 [patent_title] => MTORC MODULATORS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/553409 [patent_app_country] => US [patent_app_date] => 2021-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40730 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -32 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17553409 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/553409
mTORC modulators and uses thereof Dec 15, 2021 Issued
Array ( [id] => 17671072 [patent_doc_number] => 20220184239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS [patent_app_type] => utility [patent_app_number] => 17/539442 [patent_app_country] => US [patent_app_date] => 2021-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22417 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17539442 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/539442
METHODS AND COMPOSITIONS FOR 18F-RADIOLABELING OF BIOLOGICS Nov 30, 2021 Pending
Array ( [id] => 17671067 [patent_doc_number] => 20220184234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-16 [patent_title] => METABOLIC TARGETING OF LOW GRADE TUMORS [patent_app_type] => utility [patent_app_number] => 17/537029 [patent_app_country] => US [patent_app_date] => 2021-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537029 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/537029
METABOLIC TARGETING OF LOW GRADE TUMORS Nov 28, 2021 Abandoned
Array ( [id] => 17658456 [patent_doc_number] => 20220178921 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-06-09 [patent_title] => 4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 17/454300 [patent_app_country] => US [patent_app_date] => 2021-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14071 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 1 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17454300 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/454300
4,4-DISUBSTITUTED CYCLOHEXYL BRIDGED HEPTAMETHINE CYANINE DYES AND USES THEREOF Nov 9, 2021 Abandoned
Array ( [id] => 17342234 [patent_doc_number] => 20220008565 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => Enhanced in Vivo Targeting of Site-Specific Drugs [patent_app_type] => utility [patent_app_number] => 17/484727 [patent_app_country] => US [patent_app_date] => 2021-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10605 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -36 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484727 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/484727
Enhanced in Vivo Targeting of Site-Specific Drugs Sep 23, 2021 Pending
Array ( [id] => 16930696 [patent_doc_number] => 20210196585 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-01 [patent_title] => BIODEGRADABLE MICROBEADS [patent_app_type] => utility [patent_app_number] => 17/199950 [patent_app_country] => US [patent_app_date] => 2021-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11276 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17199950 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/199950
BIODEGRADABLE MICROBEADS Mar 11, 2021 Abandoned
Array ( [id] => 20491453 [patent_doc_number] => 12533308 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-27 [patent_title] => Water-dispersible, oil-free, and UV-blocking cosmetic composition and preparation method therefor [patent_app_type] => utility [patent_app_number] => 17/798238 [patent_app_country] => US [patent_app_date] => 2021-02-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 2098 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 179 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17798238 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/798238
Water-dispersible, oil-free, and UV-blocking cosmetic composition and preparation method therefor Feb 8, 2021 Issued
Array ( [id] => 16779410 [patent_doc_number] => 20210116488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-22 [patent_title] => Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors [patent_app_type] => utility [patent_app_number] => 17/109010 [patent_app_country] => US [patent_app_date] => 2020-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4550 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17109010 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/109010
Quantum Converting Nanoparticles as In Vivo and In Situ Optical Electric Field Sensors Nov 30, 2020 Abandoned
Array ( [id] => 20465347 [patent_doc_number] => 12521376 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-01-13 [patent_title] => Gel-chewable dosage form [patent_app_type] => utility [patent_app_number] => 17/753648 [patent_app_country] => US [patent_app_date] => 2020-09-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 1185 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 208 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17753648 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/753648
Gel-chewable dosage form Sep 14, 2020 Issued
Array ( [id] => 20621661 [patent_doc_number] => 12589155 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2026-03-31 [patent_title] => Efficient synthesis of lipid-fluorescein conjugates for CAR-T cell therapy [patent_app_type] => utility [patent_app_number] => 17/625066 [patent_app_country] => US [patent_app_date] => 2020-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 7 [patent_no_of_words] => 4613 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625066 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/625066
Efficient synthesis of lipid-fluorescein conjugates for CAR-T cell therapy Jul 1, 2020 Issued
Array ( [id] => 17748305 [patent_doc_number] => 20220226508 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => METHODS AND COMPOSITIONS FOR TREATING EPILEPSY [patent_app_type] => utility [patent_app_number] => 17/595823 [patent_app_country] => US [patent_app_date] => 2020-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20950 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17595823 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/595823
METHODS AND COMPOSITIONS FOR TREATING EPILEPSY May 27, 2020 Abandoned
Array ( [id] => 17805970 [patent_doc_number] => 20220257805 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-08-18 [patent_title] => PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206 [patent_app_type] => utility [patent_app_number] => 17/613407 [patent_app_country] => US [patent_app_date] => 2020-05-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25389 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17613407 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/613407
PHARMACEUTICAL FORMULATIONS AND METHODS FOR DELIVERING A THERAPEUTIC, DIAGNOSTIC, OR IMAGING AGENT TO CD206 May 19, 2020 Abandoned
Menu